is an industry
leading manufacturer of high-
performance molecular sieves.
The company’s commitment
to quality and performance is
unmatched within the industry.
Zeochem is dedicated to
developing the next generation
of ZEOX® molecular sieves for
the advancement of the medical
oxygen market. Its team works
closely with concentrator
producers to assist in design,
production, and overall
quality of medical oxygen
For more information, visitwww.zeochem.com
No matter how the company gets its product out there,
Inogen is able to capture the entire market. While end
users—the patients—are the key demographic, Inogen
also sells its products to home care companies if they
Because the company has the whole market at its fingertips
so to speak, Inogen is able to put more capital into research
and development. It’s a full-circle approach from patient
feedback, to R&D, to providing devices sooner to its clients.
And it works.
It’s just another way Inogen sets itself apart in this
marketplace, and its suppliers and partners see this too.
“Our competitors are so focused on driving the cost out of
their final products that they tend to just look for low-cost
parts—commodity parts that are mass produced,” Wilkinson
shared. “We’re more interested in the right part that allows
us to build the product geared towards patient preference—
one that’s quality, reliable, and helps us work towards the
lowest total cost. We don’t usually bid out parts for the
lowest price. Our suppliers find that refreshing.”